Peptidic phosphinyloxymethyl ketones as interleukin-1.beta.-converting enzyme inhibitors
US5843905A · kind A · utility
4Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 1996 |
| Grant date | Dec 1, 1998 |
| Priority date | — |
| Expiry date | Feb 6, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds, compositions and methods for inhibiting interleukin -1.beta. protease activity, the compounds having the structure of formula (1) as described in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.